We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Olive Oil's Oleic Acid Suppresses Breast Cancer

By Biotechdaily staff writers
Posted on 20 Jan 2005
Researchers have found that oleic acid, a fatty acid occurring in high concentrations in olive oil, one of the main components of the Mediterranean diet, has a suppressive effect on breast cancer cells and augments the effectiveness of trastuzumab, an important chemotherapy agent for the treatment of breast cancer.

Investigators at Northwestern University School of Medicine (Chicago, IL, USA) worked with BT-474 and SKBr-3 breast cancer cells, which naturally exhibit amplification of the HER2/neu oncogene. More...
They used an assortment of methods including flow cytometry, western blotting, immunofluorescence microscopy, metabolic status (MTT), soft-agar colony formation, enzymatic in situ labeling of apoptosis-induced DNA double-strand breaks (TUNEL assay analyses), and caspase-3-dependent poly-ADP ribose polymerase (PARP) cleavage assays to evaluate the effect of added oleic acid on the cancer cells and especially on the activity of the HER-2/neu gene.

They reported in the January 10, 2005, online edition of the Annals of Oncology that oleic acid reduced the activity of HER2/neu by up to 46%. When given together with trastuzumab, oleic acid enhanced the ability of trastuzumab to inhibit signaling pathways downstream of HER2/neu, including phosphoproteins such as AKT and MAPK. Furthermore, oleic acid increased the expression of the p27Kip1 protein, a tumor suppresser protein, which has been implicated in the development of resistance to trastuzumab treatment.

First author Dr. Javier Menendez, assistant professor at the Northwestern University School of Medicine, said, "Our findings underpin epidemiological studies that show that the Mediterranean diet has significant protective effects against cancer, heart disease, and aging. They may also help in designing future epidemiological studies and, eventually, dietary counseling to delay or prevent drug resistance developing in patients.”



Related Links:
Northwestern School of Medicine >

New
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.